Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its structural features enable selective interactions with biological targets, making it valuable in creating active ingredients for neurological and psychiatric disorders. The presence of hydroxyl and trifluoromethyl groups supports high binding affinity and metabolic stability, enhancing drug efficacy and bioavailability. Commonly employed in the production of investigational antidepressants and antipsychotics.